Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2004

View Archived Issues

Targeting telomerase for multiple myeloma therapy

Phase I pilot trial of L612 HuMAb in metastatic melanoma

Array BioPharma signs for use of CyDex's Captisol

TopoTarget and deCODE collaborate on improved cancer treatments

Series B financing to fund development of BioRexis' biopharmaceuticals

SurroMed and Biogen Idec extend collaborative research agreement

Xenova focuses on highest potential clinical stage programs

Aprepitant enhances the efficacy of standard antiemetics for chemotherapy patients

Aloxi incorporated in NCCN antiemetic guidelines for CINV

Promising candidate for treatment of acute stroke

ChemoCentryx and Forest collaborate on chemokine-based therapeutics

New inhibitors of VEGFR2 and FGFR1 identified by BMS scientists

Argenta describes new HDAC inhibitors and their use in cancer and other disorders

AstraZeneca team prepares and tests new Tie-2 inhibitors

Novel antiinflammatory erythromycins devoid of antibiotic activity claimed by Zambon

Bayer scientists design novel alpha7 nAchR agonists

Three related series of chemokine CCR5 modulators reported by GSK

Protective effects of pexelizumab in AMI patients

Avasimibe prevents plaque progression in patients with coronary atherosclerosis

Good safety profile of CVT-3146 in myocardial perfusion imaging

ED-71 increases bone formation and reduces bone resorption after bone marrow ablation in mice

TP-508 promotes fracture healing in rats via enhancement of immune responses

Antisense GHR inhibitor shows promise in animal studies

Crucell and NeoTropiX enter PER.C6 technology licensing agreement

Cypher sirolimus-eluting stent one step away from Japanese approval

Raptiva receives Swiss approval

Enrollment completed in phase III traumatic brain injury study of dexanabinol

Novo Nordisk obtains North American rights to IL-20

Panacos studies HIV maturation inhibitor in phase I trial

A-HeFT trial of BiDil cleared to continue by DSMB

Zydus Cadila launches Nucoxia in India

FGF-18 promotes cartilage repair in a rat model of injury-induced osteoarthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...